|
US20100222316A1
(en)
|
2004-04-29 |
2010-09-02 |
Abbott Laboratories |
Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme
|
|
US7880001B2
(en)
|
2004-04-29 |
2011-02-01 |
Abbott Laboratories |
Inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme
|
|
US8415354B2
(en)
|
2004-04-29 |
2013-04-09 |
Abbott Laboratories |
Methods of use of inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme
|
|
TWI350168B
(en)
|
2004-05-07 |
2011-10-11 |
Incyte Corp |
Amido compounds and their use as pharmaceuticals
|
|
JP2008504276A
(ja)
*
|
2004-06-24 |
2008-02-14 |
インサイト・コーポレイション |
アミド化合物およびその医薬としての使用
|
|
US20060009491A1
(en)
*
|
2004-06-24 |
2006-01-12 |
Incyte Corporation |
Amido compounds and their use as pharmaceuticals
|
|
EP1758882A4
(en)
*
|
2004-06-24 |
2008-01-23 |
Incyte Corp |
AMID COMPOUNDS AND THEIR USE AS MEDICAMENTS
|
|
CA2570637A1
(en)
|
2004-06-24 |
2006-02-02 |
Wenqing Yao |
N-substituted piperidines and their use as pharmaceuticals
|
|
CA2584502A1
(en)
*
|
2004-06-24 |
2006-01-05 |
Incyte Corporation |
2-methylpropanamides and their use as pharmaceuticals
|
|
JP2008504278A
(ja)
*
|
2004-06-24 |
2008-02-14 |
インサイト・コーポレイション |
アミド化合物およびその医薬としての使用
|
|
CN101080226A
(zh)
*
|
2004-08-10 |
2007-11-28 |
因塞特公司 |
酰氨基化合物及它们作为药物的用途
|
|
US8110581B2
(en)
|
2004-11-10 |
2012-02-07 |
Incyte Corporation |
Lactam compounds and their use as pharmaceuticals
|
|
BRPI0518281A2
(pt)
*
|
2004-11-18 |
2008-11-18 |
Incyte Corp |
inibidores de 11-beta hidroxilesteràide desidrogenase do tipo i e mÉtodos uso dos mesmos
|
|
US8198331B2
(en)
|
2005-01-05 |
2012-06-12 |
Abbott Laboratories |
Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme
|
|
CN103242192B
(zh)
|
2005-01-05 |
2016-05-04 |
Abbvie公司 |
11-β-羟甾类脱氢酶1型酶的抑制剂
|
|
US20090192198A1
(en)
|
2005-01-05 |
2009-07-30 |
Abbott Laboratories |
Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme
|
|
EP2835367A1
(en)
|
2005-01-05 |
2015-02-11 |
AbbVie Inc. |
Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme
|
|
WO2006126654A1
(ja)
*
|
2005-05-26 |
2006-11-30 |
Daiichi Sankyo Company, Limited |
新規化合物 コレト酸
|
|
WO2007038138A2
(en)
*
|
2005-09-21 |
2007-04-05 |
Incyte Corporation |
Amido compounds and their use as pharmaceuticals
|
|
TW200804382A
(en)
*
|
2005-12-05 |
2008-01-16 |
Incyte Corp |
Lactam compounds and methods of using the same
|
|
US7998959B2
(en)
*
|
2006-01-12 |
2011-08-16 |
Incyte Corporation |
Modulators of 11-β hydroxyl steroid dehydrogenase type 1, pharmaceutical compositions thereof, and methods of using the same
|
|
KR20080091503A
(ko)
*
|
2006-01-31 |
2008-10-13 |
인사이트 코포레이션 |
아미도 화합물 및 약제로서의 이의 용도
|
|
WO2007101270A1
(en)
*
|
2006-03-02 |
2007-09-07 |
Incyte Corporation |
MODULATORS OF 11-β HYDROXYL STEROID DEHYDROGENASE TYPE 1, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS OF USING THE SAME
|
|
WO2007103719A2
(en)
*
|
2006-03-03 |
2007-09-13 |
Incyte Corporation |
MODULATORS OF 11-β HYDROXYL STEROID DEHYDROGENASE TYPE 1, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS OF USING THE SAME
|
|
MY148128A
(en)
|
2006-04-21 |
2013-02-28 |
Lilly Co Eli |
Cyclohexylpyrazole-lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
|
|
CN101541747B
(zh)
|
2006-04-21 |
2012-11-14 |
伊莱利利公司 |
作为11-β-羟基甾族化合物脱氢酶1的抑制剂的联苯基酰胺内酰胺衍生物
|
|
WO2007124329A1
(en)
|
2006-04-21 |
2007-11-01 |
Eli Lilly And Company |
Cyclohexylimidazole lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
|
|
JP5118692B2
(ja)
|
2006-04-24 |
2013-01-16 |
イーライ リリー アンド カンパニー |
１１−β−ヒドロキシステロイドデヒドロゲナーゼ１の阻害剤としてのシクロヘキシル置換ピロリジノン
|
|
CN101432275B
(zh)
|
2006-04-24 |
2013-10-30 |
伊莱利利公司 |
11-β-羟类固醇脱氢酶1的抑制剂
|
|
ATE473210T1
(de)
|
2006-04-24 |
2010-07-15 |
Lilly Co Eli |
Substituierte pyrrolidinone als hemmer von 11- beta-hydroxysteroiddehydrogenase 1
|
|
PL2021337T3
(pl)
|
2006-04-25 |
2010-06-30 |
Lilly Co Eli |
Inhibitory dehydrogenazy 11-beta-hydroksysteroidowej typu 1
|
|
ES2344616T3
(es)
|
2006-04-25 |
2010-09-01 |
ELI LILLY & COMPANY |
Inhibidores de 11-beta-hidroxiesteroide deshidrogenasa 1.
|
|
EP2016071B1
(en)
|
2006-04-25 |
2013-07-24 |
Eli Lilly And Company |
Inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
|
|
US7829582B2
(en)
|
2006-04-28 |
2010-11-09 |
Eli Lilly And Company |
Piperidinyl substituted pyrrolidinones as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
|
|
WO2007130898A1
(en)
*
|
2006-05-01 |
2007-11-15 |
Incyte Corporation |
TETRASUBSTITUTED UREAS AS MODULATORS OF 11-β HYDROXYL STEROID DEHYDROGENASE TYPE 1
|
|
PE20110235A1
(es)
|
2006-05-04 |
2011-04-14 |
Boehringer Ingelheim Int |
Combinaciones farmaceuticas que comprenden linagliptina y metmorfina
|
|
US7838544B2
(en)
*
|
2006-05-17 |
2010-11-23 |
Incyte Corporation |
Heterocyclic inhibitors of 11-β hydroxyl steroid dehydrogenase type 1 and methods of using the same
|
|
PE20080212A1
(es)
|
2006-06-27 |
2008-04-25 |
Sanofi Aventis |
Derivados de ureas de piperidina o pirrolidina como moduladores de la 11b-hidroxiesteroide deshidrogenasa tipo 1 (11bhsd1)
|
|
TW200811170A
(en)
|
2006-06-27 |
2008-03-01 |
Sanofi Aventis |
Urea derivatives of tropane, their preparation and their therapeutic application
|
|
WO2008079945A2
(en)
*
|
2006-12-20 |
2008-07-03 |
University Of South Florida |
Rock inhibitors and uses thereof
|
|
WO2008090944A1
(ja)
|
2007-01-25 |
2008-07-31 |
Takeda Pharmaceutical Company Limited |
スピロ環化合物
|
|
WO2008096746A1
(ja)
*
|
2007-02-06 |
2008-08-14 |
Takeda Pharmaceutical Company Limited |
スピロ化合物およびその用途
|
|
JPWO2008102749A1
(ja)
|
2007-02-20 |
2010-05-27 |
武田薬品工業株式会社 |
複素環化合物
|
|
CA2678577A1
(en)
*
|
2007-02-26 |
2008-09-04 |
Vitae Pharmaceuticals, Inc. |
Cyclic urea and carbamate inhibitors of 11.beta.-hydroxysteroid dehydrogenase 1
|
|
WO2008142859A1
(ja)
*
|
2007-05-18 |
2008-11-27 |
Kowa Company, Ltd. |
新規なスピロオキシインドール化合物及びこれを含有する医薬
|
|
AU2014218443B2
(en)
*
|
2007-06-21 |
2016-05-19 |
Incyte Holdings Corporation |
Spirocycles as inhibitors of 11-beta hydroxyl steroid dehydrogenase type 1
|
|
CL2008001839A1
(es)
|
2007-06-21 |
2009-01-16 |
Incyte Holdings Corp |
Compuestos derivados de 2,7-diazaespirociclos, inhibidores de 11-beta hidroxil esteroide deshidrogenasa tipo 1; composicion farmaceutica que comprende a dichos compuestos; utiles para tratar la obesidad, diabetes, intolerancia a la glucosa, diabetes tipo ii, entre otras enfermedades.
|
|
US8575156B2
(en)
*
|
2007-07-26 |
2013-11-05 |
Vitae Pharmaceuticals, Inc. |
Cyclic inhibitors of 11β-hydroxysteroid dehydrogenase 1
|
|
JP5736098B2
(ja)
|
2007-08-21 |
2015-06-17 |
アッヴィ・インコーポレイテッド |
中枢神経系障害を治療するための医薬組成物
|
|
AR069207A1
(es)
*
|
2007-11-07 |
2010-01-06 |
Vitae Pharmaceuticals Inc |
Ureas ciclicas como inhibidores de la 11 beta - hidroxi-esteroide deshidrogenasa 1
|
|
WO2009075835A1
(en)
|
2007-12-11 |
2009-06-18 |
Vitae Pharmaceutical, Inc |
CYCLIC UREA INHIBITORS OF 11β-HYDROXYSTEROID DEHYDROGENASE 1
|
|
TWI431010B
(zh)
|
2007-12-19 |
2014-03-21 |
Lilly Co Eli |
礦皮質素受體拮抗劑及使用方法
|
|
TW200934490A
(en)
*
|
2008-01-07 |
2009-08-16 |
Vitae Pharmaceuticals Inc |
Lactam inhibitors of 11 &abgr;-hydroxysteroid dehydrogenase 1
|
|
JP5490020B2
(ja)
*
|
2008-01-24 |
2014-05-14 |
ヴァイティー ファーマシューティカルズ，インコーポレイテッド |
１１β−ヒドロキシステロイドデヒドロゲナーゼ１の環状カルバゼート及びセミカルバジドインヒビター
|
|
EP2252598A2
(en)
*
|
2008-02-11 |
2010-11-24 |
Vitae Pharmaceuticals, Inc. |
1,3-oxazepan-2-one and 1,3-diazepan-2-one inhibitors of 11beta-hydroxysteroid dehydrogenase 1
|
|
US8598160B2
(en)
*
|
2008-02-15 |
2013-12-03 |
Vitae Pharmaceuticals, Inc. |
Cycloalkyl lactame derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
|
|
CA2718264A1
(en)
*
|
2008-03-18 |
2009-09-24 |
Vitae Pharmaceuticals, Inc. |
Inhibitors of 11beta-hydroxysteroid dehydrogenase type 1
|
|
WO2009134387A1
(en)
|
2008-05-01 |
2009-11-05 |
Vitae Pharmaceuticals, Inc. |
Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
|
|
NZ588954A
(en)
|
2008-05-01 |
2012-08-31 |
Vitae Pharmaceuticals Inc |
Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
|
|
TW201004945A
(en)
|
2008-05-01 |
2010-02-01 |
Vitae Pharmaceuticals Inc |
Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
|
|
EP2291373B1
(en)
*
|
2008-05-01 |
2013-09-11 |
Vitae Pharmaceuticals, Inc. |
Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
|
|
US20100022572A1
(en)
|
2008-07-18 |
2010-01-28 |
Kowa Company, Ltd. |
Novel spiro compound and medicine comprising the same
|
|
TW201016691A
(en)
|
2008-07-25 |
2010-05-01 |
Boehringer Ingelheim Int |
Inhibitors of 11beta-hydroxysteroid dehydrogenase 1
|
|
CN104327062A
(zh)
|
2008-07-25 |
2015-02-04 |
贝林格尔·英格海姆国际有限公司 |
11β-羟基类固醇脱氢酶1的环状抑制剂
|
|
TW201010975A
(en)
*
|
2008-08-29 |
2010-03-16 |
Kowa Co |
1-adamantylazetidin-2-one derivatives and drugs containing same
|
|
GB0818241D0
(en)
*
|
2008-10-06 |
2008-11-12 |
Cancer Res Technology |
Compounds and their use
|
|
WO2010050191A1
(ja)
|
2008-10-29 |
2010-05-06 |
興和株式会社 |
１，２－ジアゼチジン－３－オン誘導体及びこれを含有する医薬
|
|
EP2393807B1
(en)
|
2009-02-04 |
2013-08-14 |
Boehringer Ingelheim International GmbH |
Cyclic inhibitors of 11 -hydroxysteroid dehydrogenase 1
|
|
JP2012136439A
(ja)
*
|
2009-04-24 |
2012-07-19 |
Nippon Chemiphar Co Ltd |
ジアザスピロアルカン誘導体
|
|
TW201039034A
(en)
*
|
2009-04-27 |
2010-11-01 |
Chunghwa Picture Tubes Ltd |
Pixel structure and the method of forming the same
|
|
MA33216B1
(fr)
|
2009-04-30 |
2012-04-02 |
Boehringer Ingelheim Int |
Inhibiteurs cycliques de la 11béta-hydroxysteroïde déshydrogénase 1
|
|
GEP20156309B
(en)
*
|
2009-04-30 |
2015-07-10 |
Vitae Pharmaceuticals Inc |
Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
|
|
US8329904B2
(en)
*
|
2009-05-12 |
2012-12-11 |
Hoffmann-La Roche Inc. |
Azacyclic derivatives
|
|
WO2011011123A1
(en)
|
2009-06-11 |
2011-01-27 |
Vitae Pharmaceuticals, Inc. |
Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1 based on the 1,3 -oxazinan- 2 -one structure
|
|
EP2448928B1
(en)
|
2009-07-01 |
2014-08-13 |
Vitae Pharmaceuticals, Inc. |
Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
|
|
US8389539B2
(en)
*
|
2009-12-01 |
2013-03-05 |
Hoffman-La Roche Inc. |
Azacyclic derivatives
|
|
CN102267995A
(zh)
*
|
2010-06-04 |
2011-12-07 |
艾琪康医药科技（上海）有限公司 |
一种制备二氮杂螺环化合物的方法
|
|
JP5860042B2
(ja)
|
2010-06-16 |
2016-02-16 |
ヴァイティー ファーマシューティカルズ，インコーポレイテッド |
置換５、６及び７員複素環、そのような化合物を含有する医薬及びそれらの使用
|
|
EP2585444B1
(en)
|
2010-06-25 |
2014-10-22 |
Boehringer Ingelheim International GmbH |
Azaspirohexanones as inhibitors of 11-beta-hsd1 for the treatment of metabolic disorders
|
|
BR112013000249A2
(pt)
*
|
2010-07-13 |
2016-05-24 |
Hoffmann La Roche |
novos compostos azacíclicos
|
|
US8552024B2
(en)
*
|
2010-08-13 |
2013-10-08 |
Hoffman-La Roche Inc. |
Azacyclic compounds
|
|
EA201300522A1
(ru)
|
2010-11-02 |
2013-11-29 |
Бёрингер Ингельхайм Интернациональ Гмбх |
Фармацевтические комбинации для лечения метаболических нарушений
|
|
JPWO2013115294A1
(ja)
*
|
2012-01-31 |
2015-05-11 |
東レ株式会社 |
ジアザスピロウレア誘導体及びその医薬用途
|
|
EP3235813A1
(en)
|
2016-04-19 |
2017-10-25 |
Cidqo 2012, S.L. |
Aza-tetra-cyclo derivatives
|
|
US10414774B2
(en)
*
|
2016-08-15 |
2019-09-17 |
Merck Sharp & Dohme Corp. |
Compound useful for altering the levels of bile acids for the treatment of diabetes and cardiometabolc disease
|
|
WO2018034917A1
(en)
*
|
2016-08-15 |
2018-02-22 |
Merck Sharp & Dohme Corp. |
Compounds useful for altering the levels of bile acids for the treatment of diabetes and cardiometabolic disease
|
|
MA46589A
(fr)
|
2016-10-24 |
2019-08-28 |
Yumanity Therapeutics Inc |
Composés et utilisations de ces derniers
|
|
EP3566055B1
(en)
|
2017-01-06 |
2025-03-12 |
Janssen Pharmaceutica NV |
Scd inhibitor for the treatment of neurological disorders
|
|
CA3083000A1
(en)
|
2017-10-24 |
2019-05-02 |
Yumanity Therapeutics, Inc. |
Compounds and uses thereof
|
|
ES3043183T3
(en)
|
2018-03-23 |
2025-11-25 |
Janssen Pharmaceutica Nv |
Compounds and uses thereof
|
|
MX2021008903A
(es)
|
2019-01-24 |
2021-11-04 |
Yumanity Therapeutics Inc |
Compuestos y usos de los mismos.
|
|
EA202192047A1
(ru)
|
2019-11-13 |
2021-12-08 |
Юманити Терапьютикс, Инк. |
Соединения и их применение
|